vidarabine phosphate and Carcinoma

vidarabine phosphate has been researched along with Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biagiotti, S; De Marco, C; Dominici, S; Magnani, M; Orlotti, N; Pierigè, F; Rossi, L; Serafini, S; Zaffaroni, N1
Belt, RJ; Coltman, CA; Costanzi, JJ; Crowley, J; Hynes, HE; Taylor, SA; Von Hoff, DD; Weiss, GR1
Coltman, CA; Fleming, TR; Harvey, WH; Katterhagen, JG; Von Hoff, DD1

Other Studies

3 other study(ies) available for vidarabine phosphate and Carcinoma

ArticleYear
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.
    International journal of oncology, 2010, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arabinonucleotides; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytotoxins; DNA, Neoplasm; Drug Delivery Systems; Drug Evaluation, Preclinical; Erythrocytes; Female; Flow Cytometry; Humans; Time Factors; Vidarabine Phosphate

2010
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:9

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Arabinonucleotides; Carcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vidarabine Phosphate

1986
Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adult; Aged; Arabinonucleotides; Carcinoma; Colonic Neoplasms; Drug Evaluation; Humans; Middle Aged; Rectal Neoplasms; Vidarabine Phosphate

1987